Related references
Note: Only part of the references are listed.Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport
Florence T. H. Wu et al.
PHYSIOLOGICAL GENOMICS (2009)
A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap
Florence T. H. Wu et al.
PLOS ONE (2009)
A compartment model of VEGF distribution in blood, healthy and diseased tissues
Marianne O. Stefanini et al.
BMC SYSTEMS BIOLOGY (2008)
Systems Biology of Vascular Endothelial Growth Factors
Feilim Mac Gabhann et al.
MICROCIRCULATION (2008)
Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
C. Kut et al.
BRITISH JOURNAL OF CANCER (2007)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Robert Roskoski
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle
Feilim Mac Gabhann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiogenic growth factor response to acute systemic exercise in human skeletal muscle
TP Gavin et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
SM Eppler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors
D Feng et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)